Correlation Between Walker Dunlop and AcelRx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and AcelRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and AcelRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and AcelRx Pharmaceuticals, you can compare the effects of market volatilities on Walker Dunlop and AcelRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of AcelRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and AcelRx Pharmaceuticals.

Diversification Opportunities for Walker Dunlop and AcelRx Pharmaceuticals

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Walker and AcelRx is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and AcelRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AcelRx Pharmaceuticals and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with AcelRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AcelRx Pharmaceuticals has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and AcelRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Walker Dunlop and AcelRx Pharmaceuticals

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 0.35 times more return on investment than AcelRx Pharmaceuticals. However, Walker Dunlop is 2.82 times less risky than AcelRx Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. AcelRx Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  7,931  in Walker Dunlop on August 31, 2024 and sell it today you would earn a total of  3,151  from holding Walker Dunlop or generate 39.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy28.51%
ValuesDaily Returns

Walker Dunlop  vs.  AcelRx Pharmaceuticals

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Walker Dunlop may actually be approaching a critical reversion point that can send shares even higher in December 2024.
AcelRx Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AcelRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, AcelRx Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Walker Dunlop and AcelRx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and AcelRx Pharmaceuticals

The main advantage of trading using opposite Walker Dunlop and AcelRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, AcelRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AcelRx Pharmaceuticals will offset losses from the drop in AcelRx Pharmaceuticals' long position.
The idea behind Walker Dunlop and AcelRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios